Clinical Trial Detail

NCT ID NCT03696030
Title HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors City of Hope Medical Center
Indications

Advanced Solid Tumor

Therapies

HER2 CAR-T cells

Age Groups: senior adult

Additional content available in CKB BOOST